ReviewFrontiers in pharmacology2022
LncRNA MEG3: Potential stock for precision treatment of cardiovascular diseases.
Zining Li et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
20 papers cite it
this papercites it
ReviewFrontiers in pharmacology2022
Zining Li et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.